4.5 Article

Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy

Paul R. Womble et al.

JOURNAL OF UROLOGY (2015)

Article Microbiology

Appropriateness of Empirical Treatment and Outcome in Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Bacteria

Florine N. J. Frakking et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Public, Environmental & Occupational Health

Secular Trends in Gram-Negative Resistance among Urinary Tract Infection Hospitalizations in the United States, 2000-2009

Marya D. Zilberberg et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)

Article Infectious Diseases

Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010

Stephen P. Hawser et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)

Article Primary Health Care

Urinary Tract Infections

Alina Wang et al.

PRIMARY CARE (2013)

Article Medicine, General & Internal

Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria

L. S. Briongos-Figuero et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)

Article Urology & Nephrology

Epidemiology, treatment and prevention of healthcare-associated urinary tract infections

F. M. E. Wagenlehner et al.

WORLD JOURNAL OF UROLOGY (2012)

Article Infectious Diseases

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK

N Woodford et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)